论文部分内容阅读
目的:观察玻璃体内注射康柏西普治疗视网膜静脉阻塞继发黄斑水肿的短期效果。方法:回顾性分析山西省人民医院2018年1月至2019年1月视网膜静脉阻塞继发黄斑水肿行玻璃体内注射康柏西普49例的临床资料。随访观察2个月。结果:治疗后1天、2周、1个月、2个月：最佳矫正视力均优于术前(n F＝85.808，n P<0.05)；黄斑中心区视网膜厚度均低于术前(n F＝92.741，n P<0.05)。n 结论:玻璃体内注射康柏西普治疗视网膜静脉阻塞继发黄斑水肿，起效迅速，短期内安全有效。“,”Objective:To observe the short-term efficacy of intravitreal injection of conbercept in the treatment of macular edema secondary to retinal vein occlusion.Methods:The clinical data of 49 eyes of 49 patients with macular edema secondary to retinal vein occlusion who received intravitreal injection of conbercept from Jan. 2018 to Jan. 2019 in Shanxi Provincial People’s Hospital were analysed retrospectively. The follow-up time was 2 months.Results:The best corrected visual acuity(BCVA) at 1 day, 2 weeks, 1 month and 2 months after treatment were better than that before surgery (n F=85.808, n P<0.05). The central macular thickness at 1 day, 2 weeks, 1 month and 2 months after treatment were all lower than that before surgery (n F=92.741, n P<0.05).n Conclusion:The intravitreal injection of conbercept is safe and effective in short time for the treatment of macular edema secondary to retinal vein occlusion.